Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Coverage of CGHS cities has expanded from 25 cities in 2014 to 80 in 2023
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
Establishes distribution center in top hub for international shipping
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Olverembatinib is the first and only third-generation BCR-ABL inhibitor approved in China for the treatment of adult patients with tyrosine kinase inhibitors
European approval is based on robust Phase III data showing Cosentyx provided rapid symptom relief from as early as Week 4, with response rates continuing to improve up to 1 year1,3-5
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Subscribe To Our Newsletter & Stay Updated
